Clinical Trial Details

Trial ID: L0572
Source ID: IRCT2016060628305N1
Associated Drug: Losartan
Title: Effects of losartan drug on liver function tests in patients with non alcoholic steatohepatitis (NASH)
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Liver function in non alcoholic steatohepatitis (NASH) patients. <br>Abnormal results of liver function studies;Abnormal results of liver function studies
Interventions: Intervention 1: In the intervention group, Losartan 50 mg tablet taken orally, once a day for six months. Intervention 2: In the control group, Amlodipine 5 mg tablets orally, once a day for six months.;Treatment - Drugs;Treatment - Drugs;In the interven
Outcome Measures: Aspartate aminotransferase. Timepoint: Before starting treatment, every two months to six months after treatment. Method of measurement: Blood sample.;Alanine aminotransferase. Timepoint: Before starting treatment, every two months to six months after treatment. Method of measurement: Blood sample.;Alkaline phosphatase. Timepoint: Before starting treatment, every two months to six months after treatment. Method of measurement: Blood sample.;Triglyceride. Timepoint: Before starting treatment, every two months to six months after treatment. Method of measurement: Blood sample.;Cholesterol. Timepoint: Before starting treatment, every two months to six months after treatment. Method of measurement: Blood sample.nan
Sponsor/Collaborators: Vice chancellor for research, Tehran University of Medical Sciences and Health Services
Gender: All
Age: 98 years56 years
Phases: Phase 2/Phase 3
Enrollment: 100
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.
Start Date: 14/08/2016
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/22985